HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intraocular inflammatory disease (uveitis) and the use of oral tolerance: a status report.

Abstract
Intraocular inflammatory disease, or uveitis, is a disorder that mostly affects children and young adults. It is the cause of about 10% of the severe visual handicap in the United States. Many of the severe, sight-threatening uveitic conditions are thought to be driven by putative autoimmune mechanisms, often with high-dose oral prednisone use as treatment, along with cytotoxic agents, antimetabolites, and cyclosporine adjunctively. The feeding of the uveitogenic retinal S-Ag to rats immunized with the same antigen resulted in clinical protection. A pilot study in which two patients, one with pars planitis and the other with Behcet's disease, were fed with the retinal S-Ag resulted in these patients' immunosuppressive medication being decreased and/or stopped. The trial also provided us with information concerning dosage and expected immune responses. A randomized, masked study looking at the effect of feeding retinal antigens to uveitis patients is ongoing.
AuthorsR B Nussenblatt, S M Whitcup, M D de Smet, R R Caspi, A T Kozhich, H L Weiner, B Vistica, I Gery
JournalAnnals of the New York Academy of Sciences (Ann N Y Acad Sci) Vol. 778 Pg. 325-37 (Feb 13 1996) ISSN: 0077-8923 [Print] United States
PMID8610986 (Publication Type: Journal Article, Review)
Chemical References
  • Antigens
  • Arrestin
  • Autoantigens
  • Eye Proteins
Topics
  • Administration, Oral
  • Adult
  • Animals
  • Antigens (administration & dosage, immunology)
  • Arrestin
  • Autoantigens (administration & dosage, immunology)
  • CD8-Positive T-Lymphocytes (immunology)
  • Cells, Cultured
  • Child
  • Clinical Trials as Topic
  • Eye Proteins (administration & dosage, immunology)
  • Humans
  • Immune Tolerance
  • Lymph Nodes (immunology)
  • Lymphocyte Activation
  • Mice
  • Pilot Projects
  • Rats
  • Rats, Inbred Lew
  • Uveitis (immunology, prevention & control, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: